Regulus Therapeutics Inc. buy HC Wainwright
Start price
19.09.23
/
50%
€1.50
Target price
19.09.24
€8.41
Performance (%)
5.33%
Price
27.08.24
€1.58
Summary
This prediction is currently active. The BUY prediction by HC_Wainwright shows slight gains of 5.33%. This prediction currently runs until 19.09.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Regulus Therapeutics Inc. | 10.714% | 10.714% |
iShares Core DAX® | 1.937% | 1.473% |
iShares Nasdaq 100 | -1.186% | -0.040% |
iShares Nikkei 225® | 1.938% | 4.205% |
iShares S&P 500 | -0.023% | 0.109% |
Comments by HC_Wainwright for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat
Stopped prediction by HC_Wainwright for Regulus Therapeutics Inc.
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.86
25.06.24
25.06.24
€9.34
25.06.25
25.06.25
-11.29%
27.08.24
27.08.24
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.26
06.05.24
06.05.24
€8.35
06.05.25
06.05.25
-26.99%
27.08.24
27.08.24
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.64
25.03.24
25.03.24
€8.30
25.03.25
25.03.25
-37.50%
27.08.24
27.08.24